www.emjreviews.com Open in urlscan Pro
2606:4700:20::681a:dac  Public Scan

Form analysis
1 forms found in the DOM

GET https://www.emjreviews.com

<form role="search" method="get" action="https://www.emjreviews.com" data-hs-cf-bound="true" data-cb-wrapper="true">
  <div class="input-button-wrapper">
    <input class="search-input" type="search" name="s" placeholder="Search" aria-label="Search the site">
    <button title="Search"><svg viewBox="0 0 19 19" fill="none" xmlns="http://www.w3.org/2000/svg">
        <path
          d="M17.9588 16.6012C18.3338 16.9762 18.3338 17.5837 17.9588 17.9587C17.5838 18.3337 16.9762 18.3337 16.6013 17.9587L11.9044 13.2637C11.7187 13.0762 11.3869 13.05 11.1769 13.1962C11.1769 13.1962 11.0456 13.2956 10.7681 13.455C9.71626 14.0568 8.49749 14.4 7.2 14.4C3.2231 14.4 0 11.1769 0 7.2C0 3.2231 3.2231 0 7.2 0C11.1769 0 14.4 3.2231 14.4 7.2C14.4 8.5069 14.0513 9.73311 13.4437 10.7888C13.2862 11.0606 13.2 11.1713 13.2 11.1713C13.0481 11.3888 13.0762 11.7188 13.2637 11.9044L17.9588 16.6012ZM7.20003 12.48C10.1156 12.48 12.48 10.1156 12.48 7.19998C12.48 4.28436 10.1156 1.91998 7.20003 1.91998C4.28441 1.91998 1.92003 4.28436 1.92003 7.19998C1.92003 10.1156 4.28441 12.48 7.20003 12.48Z"
          fill="currentColor"></path>
      </svg>
    </button>
  </div>
</form>

Text Content

EMJ COOKIES

We use cookies to ensure our website works effectively for you.

Customise Accept All
Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions.
You will find detailed information about all cookies under each consent category
below.

The cookies that are categorised as "Necessary" are stored on your browser as
they are essential for enabling the basic functionalities of the site.... Show
more


NecessaryAlways Active

Necessary cookies are required to enable the basic features of this site, such
as providing secure log-in or adjusting your consent preferences. These cookies
do not store any personally identifiable data.

 * Cookie
   __hssrc
 * Duration
   session
 * Description
   This cookie is set by Hubspot whenever it changes the session cookie. The
   __hssrc cookie set to 1 indicates that the user has restarted the browser,
   and if the cookie does not exist, it is assumed to be a new session.

 * Cookie
   __hssc
 * Duration
   30 minutes
 * Description
   HubSpot sets this cookie to keep track of sessions and to determine if
   HubSpot should increment the session number and timestamps in the __hstc
   cookie.

 * Cookie
   _ga_*
 * Duration
   1 year 1 month 4 days
 * Description
   Google Analytics sets this cookie to store and count page views.

 * Cookie
   _ga
 * Duration
   1 year 1 month 4 days
 * Description
   Google Analytics sets this cookie to calculate visitor, session and campaign
   data and track site usage for the site's analytics report. The cookie stores
   information anonymously and assigns a randomly generated number to recognise
   unique visitors.

 * Cookie
   _gid
 * Duration
   1 day
 * Description
   Google Analytics sets this cookie to store information on how visitors use a
   website while also creating an analytics report of the website's performance.
   Some of the collected data includes the number of visitors, their source, and
   the pages they visit anonymously.

 * Cookie
   ASP.NET_SessionId
 * Duration
   session
 * Description
   Issued by Microsoft's ASP.NET Application, this cookie stores session data
   during a user's website visit.

 * Cookie
   JSESSIONID
 * Duration
   session
 * Description
   New Relic uses this cookie to store a session identifier so that New Relic
   can monitor session counts for an application.

 * Cookie
   __cfruid
 * Duration
   session
 * Description
   Cloudflare sets this cookie to identify trusted web traffic.

 * Cookie
   prli_visitor
 * Duration
   1 year
 * Description
   Pretty-Link sets this cookie to store statistical information about the
   clicks made on affiliate links.

 * Cookie
   _tt_session
 * Duration
   2 days
 * Description
   Teamtailor sets this cookie to keep the context of a user.

 * Cookie
   iutk
 * Duration
   5 months 27 days
 * Description
   Issuu sets this cookie to recognise the user's device and what Issuu
   documents have been read.

Functional


Functional cookies help perform certain functionalities like sharing the content
of the website on social media platforms, collecting feedback, and other
third-party features.

 * Cookie
   __cf_bm
 * Duration
   30 minutes
 * Description
   Cloudflare set the cookie to support Cloudflare Bot Management.

 * Cookie
   lidc
 * Duration
   1 day
 * Description
   LinkedIn sets the lidc cookie to facilitate data center selection.

 * Cookie
   messagesUtk
 * Duration
   5 months 27 days
 * Description
   HubSpot sets this cookie to recognize visitors who chat via the chatflows
   tool.

 * Cookie
   UserMatchHistory
 * Duration
   1 month
 * Description
   LinkedIn sets this cookie for LinkedIn Ads ID syncing.

 * Cookie
   li_gc
 * Duration
   5 months 27 days
 * Description
   Linkedin set this cookie for storing visitor's consent regarding using
   cookies for non-essential purposes.

Analytics


Analytical cookies are used to understand how visitors interact with the
website. These cookies help provide information on metrics such as the number of
visitors, bounce rate, traffic source, etc.

 * Cookie
   debug
 * Duration
   never
 * Description
   No description available.

 * Cookie
   __hstc
 * Duration
   5 months 27 days
 * Description
   Hubspot set this main cookie for tracking visitors. It contains the domain,
   initial timestamp (first visit), last timestamp (last visit), current
   timestamp (this visit), and session number (increments for each subsequent
   session).

 * Cookie
   hubspotutk
 * Duration
   5 months 27 days
 * Description
   HubSpot sets this cookie to keep track of the visitors to the website. This
   cookie is passed to HubSpot on form submission and used when deduplicating
   contacts.

 * Cookie
   _gat_UA-*
 * Duration
   1 minute
 * Description
   Google Analytics sets this cookie for user behaviour tracking.

 * Cookie
   cb_group_id
 * Duration
   1 year
 * Description
   Clearbit sets this cookie to track page views and traits for Clearbit.

 * Cookie
   cb_anonymous_id
 * Duration
   1 year
 * Description
   Clearbit sets this cookie to track page views and traits for Clearbit.

 * Cookie
   _gcl_au
 * Duration
   3 months
 * Description
   Google Tag Manager sets the cookie to experiment advertisement efficiency of
   websites using their services.

 * Cookie
   ln_or
 * Duration
   1 day
 * Description
   Linkedin sets this cookie to registers statistical data on users' behaviour
   on the website for internal analytics.

 * Cookie
   AnalyticsSyncHistory
 * Duration
   1 month
 * Description
   Linkedin set this cookie to store information about the time a sync took
   place with the lms_analytics cookie.

 * Cookie
   CONSENT
 * Duration
   2 years
 * Description
   YouTube sets this cookie via embedded YouTube videos and registers anonymous
   statistical data.

 * Cookie
   ga_clientId
 * Duration
   never
 * Description
   Google Analytics sets this cookie to register statistical data on users'
   behavior on the website.

Performance

Performance cookies are used to understand and analyze the key performance
indexes of the website which helps in delivering a better user experience for
the visitors.

No cookies to display.

Advertisement


Advertisement cookies are used to provide visitors with customized
advertisements based on the pages you visited previously and to analyze the
effectiveness of the ad campaigns.

 * Cookie
   cb_user_id
 * Duration
   1 year
 * Description
   Clearbit sets this cookie to collect data on visitors. This information is
   used to assign visitors into segments, making website advertising more
   relevant.

 * Cookie
   IDE
 * Duration
   1 year 24 days
 * Description
   Google DoubleClick IDE cookies store information about how the user uses the
   website to present them with relevant ads according to the user profile.

 * Cookie
   li_sugr
 * Duration
   3 months
 * Description
   LinkedIn sets this cookie to collect user behaviour data to optimise the
   website and make advertisements on the website more relevant.

 * Cookie
   bcookie
 * Duration
   1 year
 * Description
   LinkedIn sets this cookie from LinkedIn share buttons and ad tags to
   recognize browser IDs.

 * Cookie
   bscookie
 * Duration
   1 year
 * Description
   LinkedIn sets this cookie to store performed actions on the website.

 * Cookie
   GoogleAdServingTest
 * Duration
   session
 * Description
   Google sets this cookie to determine what ads have been shown to the website
   visitor.

 * Cookie
   YSC
 * Duration
   session
 * Description
   Youtube sets this cookie to track the views of embedded videos on Youtube
   pages.

 * Cookie
   VISITOR_INFO1_LIVE
 * Duration
   5 months 27 days
 * Description
   YouTube sets this cookie to measure bandwidth, determining whether the user
   gets the new or old player interface.

 * Cookie
   yt-remote-device-id
 * Duration
   never
 * Description
   YouTube sets this cookie to store the user's video preferences using embedded
   YouTube videos.

 * Cookie
   yt.innertube::requests
 * Duration
   never
 * Description
   YouTube sets this cookie to register a unique ID to store data on what videos
   from YouTube the user has seen.

 * Cookie
   yt.innertube::nextId
 * Duration
   never
 * Description
   YouTube sets this cookie to register a unique ID to store data on what videos
   from YouTube the user has seen.

 * Cookie
   yt-remote-connected-devices
 * Duration
   never
 * Description
   YouTube sets this cookie to store the user's video preferences using embedded
   YouTube videos.

Uncategorized

Other uncategorized cookies are those that are being analyzed and have not been
classified into a category as yet.

No cookies to display.

Save My Preferences Accept All
Powered by
 * Therapy Area
   * Allergy & Immunology
   * Cardiology
   * Dermatology
   * Diabetes
   * Flagship Journal
   * Gastroenterology
   * General Healthcare
   * Hematology
   * Hepatology
   * Innovations
   * Interventional Cardiology
   * Microbiology & Infectious Diseases
   * Nephrology
   * Neurology
   * Oncology
   * Radiology
   * Reproductive Health
   * Respiratory
   * Rheumatology
   * Urology
 * Podcasts
 * Journals
 * Webinars
 * Collaborate
   * EMJ Media Pack
   * AMJ Media Pack
   * Editorial Enquiries
   * Contributors & Authors
   * Submit a Paper
   * Media Partners
   * Pharma Partners
   * EMJ Interactive
 * About
   * About
   * EQOH
   * Careers
   * Contact Us
 * EMJ Gold
 * search
 * Subscribe FREE

You must accept all conditions before being able to view the post
Continue
EUR USA
EUR
USA
 * Therapy Area
      
    * Allergy & Immunology
    * Cardiology
    * Dermatology
    * Diabetes
    * Flagship Journal
    * Gastroenterology
    * General Healthcare
    * Hematology
    * Hepatology
    * Innovations
    * Interventional Cardiology
    * Microbiology & Infectious Diseases
    * Nephrology
    * Neurology
    * Oncology
    * Radiology
    * Reproductive Health
    * Respiratory
    * Rheumatology
    * Urology

 * Podcasts
 * Journals
 * Webinars
 * Collaborate
      
    * EMJ Media Pack
    * AMJ Media Pack
    * Editorial Enquiries
    * Contributors & Authors
    * Submit a Paper
    * Media Partners
    * Pharma Partners
    * EMJ Interactive

 * About
      
    * About
    * EQOH
    * Careers
    * Contact Us

 * EMJ Gold
 * 
 * Subscribe FREE




Home Contributors Authors


AUTHORS


AUTHOR GUIDELINES

EMJ is an independent, open-access, eJournal dedicated to delivering first-class
insights into ground-breaking changes and advancements in medicine. Our journals
cover the following eighteen therapy areas: allergy and immunology, cardiology,
dermatology, diabetes, gastroenterology, hematology, hepatology, interventional
cardiology, medical innovations, microbiology and infectious diseases,
nephrology, neurology, oncology, radiology, reproductive health, respiratory
medicine, rheumatology and urology.

Each journal provides the reader with the latest highlights of key medical
congresses, and publishes a selection of abstract reviews, interviews and
peer-reviewed articles to name but a few of its wide content selection. EMJ, our
flagship journal, is published quarterly, bringing together an assortment of
research papers from a variety of topics across all the above therapy areas,
alongside unique features.

We welcome contributions from healthcare professionals, consultants, academics,
and industry leaders on relevant and topical subjects. We seek papers with the
most current, interesting, and relevant information in each therapeutic area.
Although many of our articles are commissioned, we also welcome unsolicited
papers. Articles accepted for publication within the eJournals and website
include original research, review articles, case reports, and feature articles
such as opinion pieces. EMJ endeavours to publish unbiased content. All articles
submitted must be of an impartial nature. Any references to companies or
products must be strictly on an essential basis only.

Please contact the Editorial team if you wish to discuss a potential topic
(editorial.assistant@emjreviews.com). Before submitting your manuscript, please
read our guidelines and editorial policies below for further information.

GUIDELINES FOR AUTHORS:

 * Reasons to Publish with Us
 * Peer Review Process
 * Submitting a Paper
 * Types of Submissions
 * Manuscript Layout and Language
 * Tables, Figures, Text boxes
 * References
 * Search Engine Optimisation (SEO) and Keywords
 * Disclosure and Conflicts of Interest
 * Authorship
 * Acknowledgements
 * Ethical Approval
 * Policy on Plagiarism
 * Permissions & Copyright
 * Proofs
 * Errors and Omissions
 * Open Access
 * Indexing
 * Submission Deadlines
 * Appeals
 * Correspondence




REASONS TO PUBLISH WITH US

 * Free publication – no article processing fees or submission charges.
 * Open access – all our journals are open access, allowing researchers,
   healthcare professionals, and the public unrestricted access to the most up
   to date research.
 * Journals published just 6 weeks after the relevant medical congress, ensuring
   your paper is part of the hot topics discussed and debated alongside the
   congress review section.
 * An expert, international editorial board and a qualified in-house editorial
   team ensuring papers are published to the highest quality.
 * Wide promotion of articles – through email alerts, newsletters, postings on
   our homepage, and press releases to the general and scientific press, all
   resulting in increased levels of access for each article. We have a social
   media audience of over 27K and a further 87K on individual therapeutic area
   Twitter accounts.




PEER REVIEW PROCESS

All submissions are initially reviewed by the Editorial team. At this stage,
papers may be rejected before peer review if we feel that they are not of high
enough quality, do not follow our guidelines, or are not within the scope of the
journal. This ensures that authors are given a quick decision if their paper is
unsuitable. Papers that pass the initial review process will be sent out for
peer review to a minimum of two independent reviewers. The process is double
blind. Papers will be selected for publication based on peer review feedback,
compliance of the author in making the modifications, and Editor’s final choice.
Articles that fail peer review will be rejected.




SUBMITTING A PAPER

Manuscripts should be submitted through our online submission system, Editorial
Manager, at http://www.editorialmanager.com/e-m-j/Default.aspx. (NB. If you are
submitting an abstract summary from a congress, then please directly email it to
the member of staff you have been in contact with about the abstract summary. Do
not submit on Editorial Manager). You will find help on how to register and step
by step instructions on how to submit your paper, but if you have any problems
or questions please contact us. Once your paper has been successfully submitted
it will be allocated a manuscript number. Please use this manuscript number in
any future correspondence.

Please ensure you have the following documents ready to upload before submitting
your manuscript on Editorial Manager:

 1. Title page – A single Word file containing the following information only:
    title of paper, names of all authors, authors’ affiliations (these should be
    linked to the authors’ names using a superscript number and should include
    the author’s name, position in their organisation, the organisation, and the
    organisation’s location), email addresses for all authors, identification of
    the corresponding author using an asterisk), and an abstract. The data
    included in this file will be used to populate information for you later in
    the submission process.
 2. Cover letter – A cover letter should be included with the submission
    outlining the importance of the paper, putting the work described into
    context, and highlighting why it is a valuable addition to the scientific
    literature. Please highlight anything particularly novel or unusual.
 3. Author Declaration of Conflicts of Interest Form – Please download and
    complete for all authors.
 4. Publishing agreement form – Please download and sign one form for all
    authors
 5. Anonymised manuscript (Word file) – Your manuscript should include the title
    of the paper, the main body of text, figure and table legends (but not the
    figure/table themselves), and reference list. See below for editorial
    formatting and style for the different types of submission. Please do not
    include anything in the manuscript that could identify the authors as this
    will be the file that is sent to the peer reviewers. NB. Please avoid
    writing statements such as “In a previous paper by the authors…”, because
    this tends to enable identification of the authors.
 6. Figures/Tables – Figures and tables should be numbered and uploaded
    separately from the manuscript. Figures should be 300 dpi JPEG or Tiff.
    Tables should be cell-based in Word or Excel.




TYPES OF SUBMISSIONS

Original research (abstract: structured, ≤250 words; main text: <3,000 words
+/-10%; combined maximum of 3 tables or figures; maximum 60 references +/-10%).

Original quantitative or qualitative research with a structured abstract and
clear Introduction, Methods, Results, Discussion (including the limitations of
the study), and Conclusion sections. We encourage authors to use the following
tools to ensure good practice in reporting their work:

 * The CONSORT checklist of items to include when reporting randomised trials.
   The STARD checklist of items for reporting studies on diagnostic accuracy.
 * If human subjects are involved the paper should include a statement that the
   patient’s written consent was obtained. Ethical approval must be sought, and
   the local ethical committees and authorising body should be stated in the
   paper.

Note: Clinical trials (where applicable) should be registered in a public trials
registry at or before the time of first patient enrolment.

Review articles (abstract: unstructured [unless a systematic review], ≤250
words; main text: <3,000 words +/-10%; maximum of 3 tables or figures; maximum
60 references +/-10%).

Reviews should provide an overview of the agreed topic but should not
recapitulate material found in textbooks. A review should offer readers an
insight into the current hot topics, latest research, and include an additional
perspective from the authors. The abstract should be unstructured (unless it is
a systematic review) and state the type of review i.e. literature review,
narrative review, and the aims and scope of the review.

If a systematic review, it should follow the PRISMA (Preferred Reporting Items
for Systematic Reviews and Meta-Analyses) checklist and guidelines. Please
structure the paper using the headings Introduction, Methods, Results,
Discussion, and Conclusion. The review should have a clearly formulated question
that uses explicit, systematic methods to identify, select, and critically
appraise relevant research, and to collect and analyse data from the studies
that are included in the review. The methods section should clearly state the
sources (databases, journal or book reference lists, etc.) of the material
covered and the criteria used to include or exclude studies. The abstract should
be structured (Background or Objective, Methods, Results, and Conclusion).

Case reports (abstract: unstructured, ≤250 words; main text: <3,000 words
+/-10%; maximum of 3 tables or figures; maximum 60 references +/-10%).

Please format your manuscript according to the CARE checklist, which can be
found here: https://www.equator-network.org/reporting-guidelines/care/.

We consider case reports that add new information or perspectives to what is
already published in the literature. The paper should highlight a particular
challenge, or a novel aspect and the lessons learnt from the case. It should
discuss the disease in the broader context, ideally give the patient’s
perspective and include any follow up. Any photos submitted should not identify
the patient or, if they do, agreement from the patient is required.

Patient Consent: Please ensure that your obtain written consent by  the patient
or their next of kin using this consent form, or an equivalent version available
at your institution. Please do not submit the completed form with your
manuscript but keep it for your own records. For more information about
obtaining patient consent please see our policy about obtaining patient consent.

 

Features (no abstract; 1,000-2,000 words; combined maximum of 3 tables or
figures; up to 10 references).

These are opinion pieces usually commissioned by the Editorial team and focus
on:

 * How a clinician would diagnose and treat a disease.
 * Discussion around established or new guidelines.
 * Critically appraising established information and ideas.
 * Illustrating how established information and ideas can be relevant in a new
   context.
 * Opinions on what future techniques/technologies/medications you would like to
   see developed.

They should be of broad interest to healthcare professionals. If you have a
potential topic you would like to write on please contact the Editorial team
first to discuss: editorial.assistant@emjreviews.com

Read our guidelines on Features for further information




MANUSCRIPT LAYOUT AND LANGUAGE

Manuscripts should be supplied in Microsoft Word, text double spaced, with all
page and line numbers included. Use headings within the text to make it easier
to read and understand. Subdivide the text into main sections with subheadings.
Keep these short and succinct and similar in sense and style. If a research
paper, include Introduction, Methods, Results, Discussion and Conclusion
headings. For case studies/series, include introduction, case description,
discussion and conclusion headings.

All articles should be written in plain English, free from jargon, and the
writing should be clear and direct. Please avoid using terms such as ‘We’, ‘Us’,
and ‘Our’. Instead, use ‘This article’ or ‘In the author’s opinion/experience’.
If English is not the authors’ first language, we recommend you ask an
English-speaking colleague to read over the paper before submitting.
Alternatively, there are English editing services you can use. Abbreviations
should be kept to a minimum and shown in full when first used.

Some further EMJ house style guidelines:

 * EMJ uses UK English. There are a few exceptions to this, including fetus.
 * In text, write out numbers one to nine, except when associated with units of
   measurement, time (exception: decade), or when in a list with other numbers
   (e.g., the trial had 12 men, 15 women, and 2 children). Use numerals for 10
   and above. Write out any number that appears at the beginning of a sentence.
 * Avoid using contractions. For example, use ‘do not’ rather than ‘don’t’.
 * Use ‘or’ rather than a slash (NB. If ‘and’ is meant, then use ‘and’). For
   example, write patients or caregivers rather than patients/caregivers.
 * Make sure you follow the guidelines provided on referencing style.
 * Use gender neutral language.
 * Write out abbreviations at their first mention in the text. Abbreviations
   should only be used if they appear at least three times in the manuscript.
 * When discussing patients, use ‘they/their’ rather than ‘he/she/his/her’.




TABLES, FIGURES, TEXT BOXES

Formatting of tables, images, and figures

These are welcome where they add emphasis, clarity, and/or interest to articles
and should be clearly labelled, accompanied by relevant titles and legends (no
more than a few lines each). If graphs, all axes should be labelled. All display
items should be referred to in the main text (Table 1, Figure 1, Box 1, etc.).
It should be noted that all tables and figures will be reformatted to match EMJ
house style.

Tables and text boxes

Tables should not exceed one A4 page (portrait). Text boxes are used to supply
additional information to supplement the text, for example listing criteria for
diagnosis or for listing advantages and disadvantages of procedures or treatment
regimens. Tables and text boxes should both be submitted in a format in which
the text is editable.

Images

Image quality needs to be at least 300 dpi in .jpeg or .tiff format to ensure
good legibility, those under 300 dpi will compromise detail.

Figures

Please submit editable, vector-based figures in one of the following accepted
vector-based formats: .eps, .ps, .ai, .svg, .ppt, and .xlsx. As a last resort if
you are unable to submit a vector-based file, please submit in one of the
following formats: .png, .jpeg, .tiff, and .bmp.

For any issues regarding figures and file types, please email us for support and
advice (editorial.assistant@emjreviews.com).

COPYRIGHT

Copyright is the legal right given to the creator of a piece of work. The types
of work to which copyright applies include literary, dramatic, musical,
artistic, sound recording, films, broadcasts and cable programmes, and
typographical arrangement of published editions. Usually for authors copyrighted
material will be figures, tables or photos. If you want to include an image in
your manuscript that you have not created, it is likely to come under copyright.
If you do not have the consent of the copyright holder, it is illegal to:

 * Copy the work
 * Adapt the work
 * Rent, lend, or provide copies of the work to the public
 * Perform, broadcast, or show the work in public

Therefore, if you include an image in your work without securing the consent of
the copyright holder, this is breaching copyright. It is possible to include
copyrighted work in your work if you obtain permission from the copyright
holder. Typically, you will need to get in touch with the Publisher of the work
to do this. If the Publisher does not have the ability to give direct
permission, they should know who you will need to contact. You should obtain
written permission, even if the copyright holder is personally known to you, as
this will avoid any future disputes. Please forward the written permission to
the editorial office. Please note, the editorial team will routinely check that
copyright permission has been granted for figures.




REFERENCES

References should be up to date. References must be numbered in order of first
mention. They must be indicated in the text by a number with the full list at
the end of the article in numerical order. No references should appear in the
abstract and references should not be provided in EndNote. References cited in
the text should be superscript (outside the punctuation where appropriate).
There should be a reference for every citation. Please check for duplicate
references.

Please ensure references follow the formats below:

 * Journal articles – Journal abbreviations are used as per the ANSI/NISO
   Z39.29-2005 (R2010) Bibliographic References standard used by MEDLINE/PubMed.

Surname & Forename Initials. Paper title. Journal name abbreviated.
Year;Volume(Issue):Page number.

(If there are only two authors then separate their names with a comma, more than
two authors and the first author names should be noted followed by ‘et al’)

For example: Lazarus K, Diggins B. Hepatic arterial embolization and
chemoembolization for imatinib-resistant gastrointestinal stromal tumours. Eur
Med J. 2013;345(16)1234-5. Please note that references should be in lowercase
after the first word apart from for proper nouns and acronyms. Please refer to
the examples below.

Wrong

Bindu Kalesan, Sandro Galea, and Jeffrey A. Fagan. Three Authors Reply. American
Journal of Epidemiology. 2017;186:897-898.

Right

Kalesan B et al. Three authors reply. Am J Epidemol. 2017;186(7):897-8.

 * Books – Surname & Initial, “title of chapter”, editored author (eds), Name of
   book (Year), City: Place of publication, pp. numbers.

For example: Poole AR et al. “Etiopathogenesis of Osteoarthritis”, Moskowitz RW
et al. (eds), Osteoarthritis: Diagnosis and Medical/Surgical Management (2007),
Philadelphia: Williams and Williams, pp. 27-49.

 * PDFs and Websites – Organisation Author (surname & forename initials). Title.
   Link. Date accessed.

For example: International Diabetes Federation. The IDF Consensus worldwide
definition on the metabolic syndrome. 2006. Available at:
http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf. Last accessed:
16th December 2015.

Note: Wikipedia cannot be cited as a reference.

 * Clinical Trials – Company. Title. [Clinical number] NCT (number). Link
   (remove hyperlink)

For example: Onyx Therapeutics, Inc. A study of carfilzomib vs best supportive
care in subjects with relapsed refractory multiple myeloma (FOCUS). NCT01302392.
http://clinicaltrials.gov/show/NCT01302392.

 * Abstracts – Surname & Forename Initials. Title. Abstract Number. Meeting,
   location dates and year.

For Example: Shah JJ et al. Phase I/II dose expansion of a multi-center trial of
carfilzomib and pomalidomide with dexamethasone (Car-Pom-d) in patients with
relapsed/refractory multiple myeloma. Abstract 690. ASD Annual Meeting, New
Orleans, Los Angeles, USA, 6-9 December, 2013.

 * Personal communication and unpublished data – Personal communications (J.
   Jones, personal communication, year) and unpublished data should be cited in
   the text and not included in the reference list. References to manuscripts
   submitted, but not yet accepted, should be cited in the text as (B. Jones and
   L. Smith, manuscript submitted).




SEARCH ENGINE OPTIMISATION (SEO) AND KEYWORDS

Why is SEO important?

Search Engine Optimisation (SEO) is the process in which we improve our content
so that it ranks highly in search engine results. This is essential in order to
get content seen, and the more times the content is seen, the more likely it is
to get used again (cited).

HOW TO CHOOSE GOOD KEYWORDS

Keywords are the words that people enter into search engines when looking for
specific things online. Therefore, you must choose the appropriate search terms
that would be used when looking for the content in your article. Keywords should
be chosen once you have finished the first draft of your text to maintain
accuracy and ensure relevance.

 * Think of 3–5 main keywords or phrases that an individual might search for to
   find your article.
 * Think of 3–5 secondary keywords, that may be alternative phrases that someone
   may use to search for your article.
 * To help, search for similar articles to yours and see what keywords they have
   used.

WHERE TO INCLUDE KEYWORDS

Keywords must be used enough so that they are flagged as relevant content to a
search engine, but it is important not to use them too much. Saturating your
article with keywords highlights abuse to a search engine, and subsequently your
article will not rank highly.

 * Title: 2–4 keywords. Include majority of keywords in the first half of the
   title
 * Abstract: 3–4 keywords. Repeat 2–3 times naturally throughout
 * Subheadings: Ensure each subheading contains at least one keyword
 * Secondary keywords should be included throughout the main text and in
   figure/table legends

HOW TO GET YOUR ARTICLE SEEN

When a link to one page is included in another page, search engines see that
link as important content. Therefore, the more times that link is included on
other pages, the more important that content seems to be. Hence, it is essential
to share your article link on as many platforms as possible. Remember: the more
times that content is seen, the more likely it is to be cited.

 * Share on social media: Facebook, Twitter, LinkedIn, Google+, ResearchGate
 * Include on professional web pages
 * Share with colleagues via email or social media

Ask co-authors, friends, and colleagues to share on their social media and
professional web pages.




DISCLOSURE AND CONFLICTS OF INTEREST

A conflict of interest can be said to exist when professional judgement
concerning the manuscript may be influenced by a secondary interest (e.g.,
financial gain). For example, this would include disclosing the names of (and
relationship with) any pharmaceutical, biologics, medical device, and diagnostic
companies for which an author (or one of their close family members) is
employed, contracted for, provides services, or has otherwise collaborated with.
It should be noted that a perception of a conflict of interest is as important
as actual conflicts of interest. This is because trust in the scientific process
and the validity and credibility of published manuscripts depend partly on the
transparency of conflict of interest.
Disclosure
All authors must disclose any potential conflicts of interest when submitting a
manuscript. These might include financial relationships with entities that could
be perceived to influence the submitted work; non-financial interests that could
impact objectivity; any relevant patents or copyrights, or any other
relationships or activities that the audience could perceive as influencing the
work.
Signed Statements: All authors must complete the Author Declaration of Conflicts
of Interest Form. Disclosures should cover relationships from 36 months prior to
submission and any relevant ongoing relationships.
Authors must disclose:
 * Direct financial relationships (e.g. employment, consultancies, stock
   ownership)
 * Research funding and grants
 * Patents (pending, issued, licensed)
 * Royalties
 * Expert testimony
 * Personal relationships that could be perceived as influencing the work
 * Institutional affiliations that could be perceived as influencing the work

Editorial Responsibilities
The Editorial Staff will evaluate disclosed conflicts to determine if they are
significant enough to preclude publication or require additional scrutiny.
Reviewers with competing interests that prevent objective evaluation should
remove themselves from the process. Editorial staff with conflicts related to a
manuscript will remove themselves from the decision making process for that
content.
All relevant conflicts of interest will be published with the article.

Please download the Author Declaration of Conflicts of Interest Form and
complete for all authors.

The ICMJE provides further guidance on conflicts of
interest: http://www.icmje.org/recommendations/browse/roles-and-responsibilities/author-responsibilities–conflicts-of-interest.html


AUTHORSHIP

Authorship implies responsibility and accountability for published work as well
as providing credit for a researcher’s contributions to a study. Assignment of
authorship is to individuals who have contributed to the analysis and
interpretation of a study but who may not have contributed to its conception and
design. The contribution and responsibility of every author should be included.
Authors may wish to acknowledge other contributors, such as a professor, who has
helped during the process but who may not have made the required contribution to
the article to be labelled as an author.

The lead author of a paper is defined as one who takes the lead for writing and
managing each publication. Clear descriptions of the role of each contributor
during preparation of the article should be included in the manuscript
submission. A medical writer may qualify for authorship if they have defined the
scope of a review article and are willing to take public responsibility for
relevant portions of the content.

EMJ’s authorship guidelines are based on the ICMJE’s guidelines. All those
designated as authors should meet the following four criteria:

 1. Substantial contributions to the conception or design of the work; or the
    acquisition, analysis, or interpretation of data for the work; and
 2. Drafting the work or revising it critically for important intellectual
    content; and
 3. Final approval of the version to be published; and
 4. Agreement to be accountable for all aspects of the work in ensuring that
    questions related to the accuracy or integrity of any part of the work are
    appropriately investigated and resolved.

Please note that all those who meet the criteria should be acknowledged as
authors. Furthermore, these criteria should not be used to disqualify those who
meet the first criterion from authorship by denying them the opportunity to meet
other criteria. For example, all those who meet the first criterion should have
the opportunity to participate in the writing, drafting, and approval of the
manuscript. Author contributions should be specified, e.g., Author A designed
the study. Authors A, B, and C analysed the study data. Author B reviewed the
literature. All authors critically reviewed the manuscript and approved the
final version for submission.

If you wish to add or remove an author after your manuscript has been submitted
and/or published, you will need to provide an explanation for the requested
change and a signed Statement of Agreement from all listed authors as well as
the author who is being added or removed.

For further guidance on authorship criteria, please see the ICMJE
recommendations.




ACKNOWLEDGEMENTS

If there is an individual or individuals who have contributed to the manuscript
(e.g., proofreading, general administrative support, general supervision of a
research group) but have not fulfilled all four criteria outlined above in the
Authorship guidelines, their contribution should be acknowledged in the
acknowledgements section. Their contribution should be specified, e.g., XXX
participated in proofreading the manuscript.

Please be aware that as acknowledging may imply an endorsement of a manuscript’s
data and conclusions, a written statement permitting acknowledgement should be
provided that has been signed by all acknowledged individuals.




ETHICAL APPROVAL

We expect that all authors conducting medical research follow the Declaration of
Helsinki, which can be viewed here:
https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/.

Research articles: Authors should be able to submit, upon request, a statement
from their institutional review board or ethics committee indicating approval of
the research. Authors should also make every effort to protect patient privacy
and anonymity. Potentially identifying information should only be included if it
is crucial and unavoidable; furthermore, the potentially identified individual
or individuals must have provided written consent for the information to be
included in this way.

Patient Consent: For case reports, authors should ensure that written consent is
obtained from the patient or their next of kin using this consent form, or an
equivalent version available at their institution. Patient consent forms should
not be submitted to to us to ensure patient confidentiality but should be kept
for the authors’ own records. For more information about obtaining patient
consent please see our policy about obtaining patient consent.




POLICY ON PLAGIARISM

By submitting your manuscript to the EMJ it is understood that it is an original
manuscript, is unpublished work and is not under consideration elsewhere.
Falsification or fabrication of data, plagiarism, including duplicate
publication of the authors’ own work without proper citation, and
misappropriation of the work are all unacceptable practices. Any cases of
ethical misconduct in this regard will be treated very seriously and dealt with
in accordance with the COPE guidelines.

For further guidance on what constitutes plagiarism, please see below. This
information has been based on the Office of Research Integrity’s Guidelines on
how to Avoid Plagiarism, which can be found
here: https://ori.hhs.gov/plagiarism-0.

According to the ORI, “plagiarism has been traditionally defined as the taking
of words, images, processes, structure and design elements, ideas, etc. of
others and presenting them as one’s own.”

 * If you borrow any ideas, data, or conclusions from others and use them as the
   cornerstone of your own manuscript, they must be properly acknowledged.
 * When copying text word-for-word, enclose that information in quotation marks
   and indicate the source of that text.
 * Plagiarism can also occur if portions of text are copied from one or more
   sources and some of the words are slightly changed but the original author(s)
   are not given acknowledgement. This can also include paraphrasing. Whether
   paraphrasing or summarising, the source of the original information should be
   identified.

For further details on what constitutes an overlapping publication, please see
below. These guidelines are based on the ICMJE recommendations, which can be
viewed here: http://www.icmje.org/icmje-recommendations.pdf.

 * Duplicate submission: The manuscript you submit should not have been
   simultaneously submitted to another journal (in the same or a different
   language).
 * Duplicate publication: Publishing a manuscript that has substantial overlap
   with a manuscript that has already been published and failing to provide a
   clear acknowledgement of the original manuscript. If your manuscript contains
   a significant proportion of work that has been published or submitted for
   publication elsewhere, please make this clear when submitting so it can be
   decided how best to handle your submission.
   * Please note that this does not prevent publication of a complete manuscript
     following publication of a preliminary report (e.g., abstract poster
     displayed at a scientific congress). Furthermore, in the case of a public
     health emergency, information that will have an immediate impact on public
     health should be shared without fear that this will prevent subsequent
     consideration for journal publication.




PERMISSIONS & COPYRIGHT

EMJ publishes journal content under a Creative Commons Attribution-Non
Commercial 4.0 licence.
This permits users to:
Share – Copy and redistribute the material in any medium or format.
Adapt – Remix, transform, and build upon the material.
Under the following terms:
Attribution – You must give appropriate credit, provide a link to the license,
and indicate if changes were made. You may do so in any reasonable manner, but
not in any way that suggests the licensor endorses you or your use of the
material.
Non-commercial – You may not use the material for commercial purposes.
No additional restrictions – You may not apply legal terms or technological
measures that legally restrict others from doing anything the license permits.
EMJ is the copyright holder of all published material, unless otherwise
specified. A form confirming copyright transfer must be signed by every author
and be submitted alongside the manuscript upon first submission. The
corresponding author is responsible for submitting this form during the
submission process.
Authors can reuse content under the terms of the CC BY-NC 4.0 licence, without
seeking prior permission.
Commercial Use
Commercial use of published content requires explicit permission from EMJ. For
commercial use requests, please contact: accountspayable@emjreviews.com .
Permissions
It is the authors’ responsibility to obtain written permission to reproduce any
content that has previously appeared in another publication and this must be
acknowledged as specified by the copyright holder. Authors must confirm they
hold the necessary rights to submit and publish the content, and have obtained
permissions for any third-party intellectual property included.In addition,
authors should provide copies of permission letters for any material reproduced
from copyrighted publications.




PROOFS

Queries may be raised to the authors while the paper is being copyedited. These
should be answered promptly to ensure there is no delay in publication. The page
proofs will be sent to the corresponding author once the paper has been
copyedited and laid out. Any requests for changes must be returned by the
deadline given. Only minor changes can be made at the proofing stage; major
changes will not be accepted. Changes submitted after the given deadline will
not be incorporated. All accepted manuscripts will be subject to editorial
revisions for clarity, punctuation, syntax, and conformity to house style.




ERRORS AND OMISSIONS

The EMJ will take every possible action to ensure that all content is reproduced
correctly; however, due to human or mechanical errors we cannot guarantee the
accuracy, adequacy, or completeness of all information and therefore cannot be
held responsible for any errors or omissions, or for the results obtained from
the use of the content thereof.




OPEN ACCESS

We are an open-access journal in accordance with the Creative Commons
Attribution-Non Commercial 4.0 (CC BY-NC 4.0)< license. This permits users to:

Share – Copy and redistribute the material in any medium or format.
Adapt – Remix, transform, and build upon the material.

Under the following terms:

Attribution – You must give appropriate credit, provide a link to the license,
and indicate if changes were made. You may do so in any reasonable manner, but
not in any way that suggests the licensor endorses you or your use of the
material.
Non-commercial – You may not use the material for commercial purposes.
No additional restrictions – You may not apply legal terms or technological
measures that legally restrict others from doing anything the license permits.




INDEXING

Various EMJ journals are indexed on Google Scholar and DOAJ.




SUBMISSION DEADLINES

For more information on our submission deadlines for each therapeutic area,
please contact editorial.assistant@emjreviews.com






APPEALS

If you would like to appeal the decision made about your manuscript, please
email editorial.assistant@emjreviews.com with the word ‘appeal’ and your
manuscript number in the subject line. Please provide detailed reasons for the
appeal and responses to any comments made by EMJ. Please be aware that only one
appeal can be considered per manuscript so do give any submitted appeal due time
and effort. Furthermore, it is EMJ’s policy that appeals will be prioritised
behind the normal workload.




CORRESPONDENCE

Please send any correspondence to editorial.assistant@emjreviews.com.

Please select
 * About Us
 * EMJ GOLD
 * Podcast: Gold with Gore
 * Careers
 * Partners & Directory
 * Compliance
 * Open Access & Copyright
 * Contact Us
 * Events
 * Contributors
 * Subscribe to our email newsletter
 * Media Pack
 * The New World of EMJ
 * FAQ
 * Editorial Policy
 * Quality Policy
 * Journals
 * Editorial Enquiries
 * Our Pharma Partners
 * EMJ & American Medical Journal’s Mission to Elevate the Quality of Healthcare
   Globally
 * EQOH Scoring
 * EMJ Interactive Content
 * Interactive Content


MORE ARTICLES

EMJ GOLD


HOOK, LINE AND SINKER: CATCHING THE ATTENTION OF HCPS

Neurology
10 Mins
18 Dec 2024


REDUCING THE CV RISKS OF SMOKING

Dermatology
17 Dec 2024


TRALOKINUMAB IN THE ERA OF DISRUPTION IN ATOPIC DERMATITIS


FEATURED JOURNALS

Cardiology
December 2024


EMJ CARDIOLOGY 12 [SUPPLEMENT 3] 2024

Flagship Journal
December 2024


EMJ 9.4 2024


ELEVATING THE QUALITY OF HEALTHCARE GLOBALLY


ELEVATING THE QUALITY OF HEALTHCARE GLOBALLY




THERAPY AREA

 * Allergy & Immunology
 * Cardiology
 * Dermatology
 * Diabetes
 * Flagship Journal
 * Gastroenterology
 * General Healthcare
 * Hematology
 * Hepatology
 * Innovations
 * Interventional Cardiology
 * Nephrology
 * Neurology
 * Oncology
 * Reproductive Health
 * Respiratory
 * Rheumatology
 * Urology


ABOUT US

 * About Us
 * EMJ GOLD
 * Podcast: Gold with Gore
 * Careers
 * Partners & Directory
 * Compliance
 * Open Access & Copyright
 * Contact Us
 * Events
 * Contributors
 * Subscribe to our email newsletter
 * Media Pack
 * The New World of EMJ
 * FAQ
 * Editorial Policy
 * Quality Policy
 * Journals
 * Editorial Enquiries
 * Our Pharma Partners
 * EMJ & American Medical Journal’s Mission to Elevate the Quality of Healthcare
   Globally
 * EQOH Scoring
 * EMJ Interactive Content
 * Interactive Content

 * 
 * 
 * 
 * 

This site is intended for healthcare professionals.

Copyright © 2024 European Medical Group LTD trading as European Medical Journal.
All rights reserved. European Medical Journal is for informational purposes and
should not be considered medical advice, diagnosis or treatment recommendations.

Ts & Cs Privacy Policy Cookie Policy

Website by Vibe Agency
 * 
 * 
 * 
 *